Nupathe Inc (NASDAQ:PATH)
| 3.16 Data as of 1:37pm ET |  0.00 / 0.00%Today’s Change | 2.47 Today|||52-Week Range 4.59 | -6.51% Year-to-Date |
Latest PATH News | Press Releases
No recent news for Nupathe Inc.
Today’s Trading
| Previous close | 3.16 |
| Today’s open | 3.12 |
| Day’s range | 3.12 - 3.17 |
| Volume | 62,777 |
| Average volume (3 months) | 159,713 |
| Market cap | $98.2M |
| Dividend yield | -- |
Data as of 1:37pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -56.96% |
| Earnings growth (this year) | +54.03% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TROVTrovagene Inc | -0.12 | -1.69% |
| LPDXLipoScience Inc | -0.05 | -0.77% |
| TTHITransition Therapeut... | +0.11 | +3.86% |
| INOInovio Pharmaceutica... | +0.04 | +5.29% |
Data as of 1:50pm ET, 05/21/2013
Financials
| Last reporting date | May 14, 2013 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$37.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Armando Anido, MBA |
President Terri B. Sebree |
Corporate headquarters Conshohocken, Pennsylvania |
Forecasts
